These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia. Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM. J Am Coll Cardiol; 2008 Apr 22; 51(16):1564-72. PubMed ID: 18420099 [Abstract] [Full Text] [Related]
7. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol. Harikrishnan S, Rajeev E, Tharakan JA, Titus T, Ajit Kumar VK, Sivasankaran S, Krishnamoorthy KM, Nair K. Indian Heart J; 2008 Apr 22; 60(3):215-22. PubMed ID: 19240310 [Abstract] [Full Text] [Related]
8. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. Pick ME, Hawrysh ZJ, Gee MI, Toth E, Garg ML, Hardin RT. J Am Diet Assoc; 1996 Dec 22; 96(12):1254-61. PubMed ID: 8948386 [Abstract] [Full Text] [Related]
12. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers. Penn R, Williams RX, Guha-Ray DK, Sawyers WG, Braun SL, Rains KT. Clin Ther; 2006 Jan 22; 28(1):45-54. PubMed ID: 16490579 [Abstract] [Full Text] [Related]
13. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D. Toxic Rep Ser; 1995 Apr 22; 30():1-G5. PubMed ID: 12209194 [Abstract] [Full Text] [Related]
18. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia. Superko HR, Garrett BC, King SB, Momary KM, Chronos NA, Wood PD. Am J Cardiol; 2009 Feb 01; 103(3):387-92. PubMed ID: 19166694 [Abstract] [Full Text] [Related]
19. Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study). Zhao XQ, Morse JS, Dowdy AA, Heise N, DeAngelis D, Frohlich J, Chait A, Albers JJ, Brown BG. Am J Cardiol; 2004 Feb 01; 93(3):307-12. PubMed ID: 14759379 [Abstract] [Full Text] [Related]
20. Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia. Maccubbin D, Bays HE, Olsson AG, Elinoff V, Elis A, Mitchel Y, Sirah W, Betteridge A, Reyes R, Yu Q, Kuznetsova O, Sisk CM, Pasternak RC, Paolini JF. Int J Clin Pract; 2008 Dec 01; 62(12):1959-70. PubMed ID: 19166443 [Abstract] [Full Text] [Related] Page: [Next] [New Search]